✦ LIBER ✦

Survival and prognostic factors of 273 Patients (PTS) with Small Cell Lung Carcinoma (SCLC) treated with alternating CT and with surgery for operable PTS

Book ID: 123311361
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 118 KB
Volume: 7
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(91)91949-C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

145PD PROGNOSTIC FACTORS FOR SURVIVAL IN

145PD PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS (PTS) WITH SMALL CELL LUNG CANCER (SCLC): VALIDATION STUDY OF A PUBLISHED CLASSIFICATION

✍ Paesmans, M.; La.tte, J.J.; Lecomte, J.; Berghmans, T.; Efremidis, A.; Meert, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Non-Small Cell Lung Cancer: Prognostic F

Non-Small Cell Lung Cancer: Prognostic Factors in Patients Treated with Surgery and Postoperative Radiation Therapy1

✍ Lee, Jason H.; Machtay, Mitchell; Kaiser, Larry R.; Friedberg, Joseph S.; Hahn, 📂 Article 📅 1999 🏛 The Radiological Society of North America 🌐 English ⚖ 102 KB

Comparison of prognostic factors and sur

Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 299 KB

91 Delivered dose intensity with an indu

91 Delivered dose intensity with an induction chemotherapy (CT) by ifosfamide, etoposide and anthracyclin for patients (PTS) with small cell lung cancer (SCLC): A report by the european lung cancer working party

✍ M. Paesmans; J.P. Sculier; G. Bureau; V. Giner; J. Thiriaux; P. Mommen; J. Klast 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Lymphovascular Invasion and pT Stage Are

Lymphovascular Invasion and pT Stage Are Prognostic Factors in Patients Treated with Radical Nephroureterectomy for Localized Upper Urinary Tract Transitional Cell Carcinoma

✍ Dong Suk Kim; Young Hoon Lee; Kang Su Cho; Nam Hoon Cho; Byung Ha Chung; Sung Jo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Prognostic factors for survival and resp

Prognostic factors for survival and response in advanced non-small cell carcinoma of the lung (NSCLC) treated with CMAP (CCNU, methotrexate, adriamycin, cisplatinum)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 94 KB